Howard & Howard Attorneys PLLC
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).
CAYMAN CHEMICAL COMPANY, INCORPORATED
C A A A A C A A A A C C C A A C A A A A A C A A A C A A A
C07D A61K A61P A61P A61P C07D A61K A61K A61P A61P C07D C07D C07D A61P A61P C07D A61P A61P A61P A61P A61P C07D A61K A61P A61P C07D A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Stephen Douglas Kirk Lang Gregory W. Fred Lawrence Pil Heui James Bernard
Barrett Olson Endres Ciske Lee Kramer